Get started

Otcstocks

TORXF breaking out for short term upside to 23 Hello Everyone, Have spotted a bullish pattern on the chart that can take the prices to 23 in the short while. Points to note: > Breaking out from Symmetrical Triangle > Forming rectangle pattern > Rising volumes on the breakout. > Hammer spotted Important levels: Support: 19.4 (lower trendline of the triangle) Resistence: 23 (supply zone confirmed twice previously) Entry Levels: 20-20.25 (weekly close above the triangle) Exit Levels: 19.3 or trail with EMA 100 once it breaches 21 levels. Risk to Reward: Optimal Entry 20 – Target 23 = Almost 4x Reward to Risk
OTC:TORXFLong
by madhubansal
What Is the Over-the-Counter (OTC) Market and How Does It Work? What Is the Over-the-Counter (OTC) Market and How Does It Work? The over-the-counter (OTC) market is a crucial yet often misunderstood part of the financial system. Unlike centralised exchanges, OTC markets offer a decentralised way to trade various securities, from bonds to currencies. This article explores how the OTC market works, its instruments, and the opportunities and risks it presents for traders and investors alike. What Is the OTC Market? The over-the-counter market meaning refers to the OTC marketplace, a decentralised network where financial assets are traded directly between buyers and sellers, rather than through a centralised exchange like the NYSE. This OTC definition highlights that trades happen via private negotiations, often facilitated by brokers or dealers. OTC markets cover a wide range of assets, including bonds, derivatives, and unlisted stocks. This market is popular for assets that are either too niche or illiquid to be traded on traditional exchanges. For example, many corporate bonds and complex derivative products are commonly traded OTC. One of the key features of the OTC market is its flexibility. Since it’s not bound by exchange rules, traders can customise contracts, including factors like trade size and terms. However, this also means less transparency, as there’s no central exchange to standardise prices. Investors also face greater counterparty risk—the risk that the other party in a trade may default. Prices can vary, and buyers often face wider bid-ask spreads due to lower liquidity. Despite this, OTC market trading plays a crucial role in global finance, especially for institutions looking for bespoke solutions or access to less commonly traded assets. Although not as accessible to retail traders, it’s vital for institutional investors, corporations, and hedge funds. How Does the Over-the-Counter Market Differ from Exchanges? The over-the-counter market and traditional exchanges both facilitate the trading of securities, but they operate in fundamentally different ways. Check out how they differ: 1. Centralisation - OTC: Decentralised, with trades occurring directly between two parties, typically via brokers or dealers, often through phone or electronic means. - Exchanges: Centralised, with all trades happening in a formal, regulated environment (e.g., the NYSE), ensuring consistent pricing. 2. Regulation - OTC: OTC trading is regulated but with fewer reporting requirements and more flexible trading terms. - Exchanges: Highly regulated, with strict oversight from government bodies (e.g., SEC) to provide transparency and protect investors. 3. Pricing Transparency - OTC: Prices are negotiated and can vary between trades. This lack of a central order book means there’s often less price visibility. - Exchanges: Transparent pricing with public order books and visible trade histories, ensuring all market participants see the same prices. 4. Liquidity - OTC: Liquidity can be lower, and bid-ask spreads can be wider, particularly for less frequently traded instruments. - Exchanges: Typically higher liquidity with narrower spreads due to the larger pool of buyers and sellers. 5. Contract Standardisation - OTC: Contracts can be customised to suit the needs of the parties involved, which is common with derivatives. - Exchanges: Contracts are standardised in terms of size, quality, and other conditions, offering uniformity across trades. 6. Counterparty Risk - OTC: Higher counterparty risk since there's no intermediary guaranteeing trades. - Exchanges: The exchange itself acts as an intermediary, reducing the risk of default. Different OTC Markets The OTC market is decentralised, but it has several key venues or platforms where securities are traded. Each market offers a different level of access and regulation. Key over-the-counter market examples include: OTCQX This is the top-tier OTC market, where companies must meet higher financial and reporting standards. It’s known for featuring well-established companies, including international firms and large corporations that don’t wish to list on major exchanges but still want access to US investors​. OTCQB Often called the "Venture Market," this tier caters to smaller or growing companies. It has less stringent requirements than OTCQX but still requires regular financial reporting and compliance with some SEC guidelines​. Pink Open Market Also known as the "Pink Sheets," this is the most speculative and riskiest OTC market. Companies listed here have minimal financial requirements, making it home to smaller, more volatile firms. Investors should approach this arena with caution due to the higher risk of lack of transparency​. Forex, Bonds, and Commodities Since OTC markets are decentralised, they are not as heavily regulated as exchange-traded markets. However, they are still subject to regulatory oversight in key jurisdictions to ensure transparency, protect participants, and prevent fraud. Types of Instruments Traded on the OTC Market The OTC market is home to a wide variety of financial instruments, many of which don’t fit neatly within the rigid structures of formal exchanges. These instruments are often more customised or involve companies that aren’t listed on major exchanges. Derivatives The OTC market is one of the primary venues for trading derivatives—an instrument based on the price movements of an underlying asset. OTC derivatives examples include CFDs, swaps, forwards, and options. These contracts are often tailored to meet the specific risk management needs of the parties involved. For instance, interest rate swaps help companies hedge against changes in borrowing costs​. The key difference between exchange-traded and OTC derivatives lies in standardisation: exchange-traded derivatives are standardised, while OTC derivatives are customised to suit specific requirements. Unlisted Stocks Shares of smaller companies that don’t meet the listing standards of major exchanges are traded OTC. These stocks can range from well-established foreign companies (through mechanisms like American Depositary Receipts) to speculative, early-stage firms​. Bonds Government and corporate bonds are frequently traded over the counter. Since bonds are typically issued in large quantities and often have specific terms, the OTC market allows for more flexibility and customisation compared to exchanges. This also includes municipal bonds, which are important for financing public projects​. Commodities Some commodities, such as gold or oil, can also be traded OTC, offering buyers and sellers a flexible way to arrange deals that aren’t subject to standardised exchange rules​. Currencies The foreign exchange (forex) market, the largest OTC market globally, involves the trading of currency pairs. While it’s a specialised space, it’s essential for international trade and finance​. Want to explore a world of currency pairs and stock and commodity CFDs? Head over to the TickTrader trading platform by FXOpen to get started. Advantages and Disadvantages of OTC Markets The OTC market offers both significant advantages and notable disadvantages, making it an important but complex space for investors. Advantages - Flexibility: OTC markets allow for greater flexibility in terms of trade size, timing, and contract structure. This is particularly valuable for derivatives and bonds, where customised terms are often crucial for hedging or managing financial risks​. - Access to Niche Markets: Many securities traded OTC, like unlisted stocks or foreign bonds, aren’t available on major exchanges. This provides investors with access to a broader range of opportunities, particularly in niche or emerging markets​. - Less Stringent Requirements: For companies, the OTC market offers a way to raise capital without the heavy regulatory burden of a stock exchange listing. This makes it a viable option for smaller or newer companies looking to grow​. Disadvantages - Lower Transparency: One of the biggest downsides of OTC trading is its lack of transparency. Prices are often not publicly available, making it harder for investors to gauge fair value​. - Higher Counterparty Risk: Since there is no centralised clearinghouse, the risk that one party might default on a trade is higher in OTC venues. This can be particularly risky in volatile conditions​. - Liquidity Issues: Liquidity can be much lower in OTC markets, especially for niche or less frequently traded securities. This means that finding a buyer or seller at the desired price may be more challenging, resulting in wider bid-ask spreads​. The Bottom Line The OTC market offers unique opportunities for traders seeking flexibility and access to specialised securities. However, it comes with its own risks. Understanding these factors is key to navigating this dynamic marketplace. To potentially mitigate risks, traders choose regulated, well-established brokers with a long history. To explore trading opportunities in the forex, stock, and commodity markets, consider opening an FXOpen account and gain access to four advanced trading platforms, blazing-fast execution speeds, and competitive trading costs. FAQ Is Forex an OTC Market? Yes, forex is an over-the-counter (OTC) market. It operates through a global, decentralised network where currencies are traded directly between participants, rather than through a central exchange. Retail traders access this market via brokers, allowing them to trade currency pairs 24/5. What Is OTC in the Stock Market? In the stock market, the OTC meaning refers to trading securities outside of formal exchanges. These are often smaller companies that don’t meet the requirements for major exchanges like the NYSE and are traded via a broker-dealer network. What Are Examples of OTC Financial Products? Examples of OTC financial products include bonds, derivatives like swaps and options, unlisted stocks, and currencies. These products are traded directly between parties, often through brokers, without a central exchange. What Is an Example of an OTC Platform? An example of an OTC platform is OTC Markets Group, which facilitates the trading of unlisted stocks through tiers like OTCQX, OTCQB, and Pink Open Market. What Is OTC in the Crypto Market*? In the cryptocurrency market*, OTC trading involves large transactions of digital assets conducted directly between buyers and sellers, often through brokers, bypassing traditional exchanges for greater privacy and flexibility. *At FXOpen UK, Cryptocurrency CFDs are only available for trading by those clients categorised as Professional clients under FCA Rules. They are not available for trading by Retail clients. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
Education
by FXOpen
1
Bayer Cuts Dividends to Reduce DebtIn a strategic move to tackle its mounting debt and enhance financial flexibility, Bayer ( OTC:BAYRY ), the German pharmaceutical giant, has announced a significant shift in its dividend policy. The decision, though met with mixed reactions from investors and analysts, underscores the company's commitment to addressing its pressing financial challenges. Facing High Debt and Challenging Cash Flow: Bayer's ( OTC:BAYRY ) decision to amend its dividend policy stems from a pressing need to mitigate its high debt burden and grapple with a challenging free cash flow situation. Chief Executive Bill Anderson emphasized the company's priority to reduce debt and increase flexibility, acknowledging the necessity of the amended dividend policy in achieving these objectives. A Drastic Reduction in Dividends: The scale of the dividend reduction is striking. From 2.40 euros per share in the previous year, Bayer ( OTC:BAYRY ) now proposes a mere 0.11 euro dividend for 2023. This substantial cut reflects the severity of the financial constraints Bayer is contending with and underscores the urgency with which it seeks to address them. Analyst Insights and Investor Reactions: Analysts at Jefferies have characterized Bayer's move as emblematic of the extensive operational and financial challenges confronting the company. They emphasize the need for further significant strategic actions to rectify the balance sheet and restore investor confidence. Investor reactions have been mixed, with some expressing understanding of the company's predicament, while others voice concerns about the implications for shareholder returns and the long-term health of the business. Strategic Imperatives: Job Cuts and Potential Breakup: Bayer's ( OTC:BAYRY ) dividend policy amendment follows a series of strategic maneuvers aimed at stabilizing its financial position and reigniting growth. In January, the company announced job cuts, signaling a commitment to streamline operations and reduce costs. Moreover, Bayer ( OTC:BAYRY ) has been exploring options to potentially dismantle its diverse portfolio, which includes prescription drugs, consumer health products, crop chemicals, and seeds. This strategic evaluation underscores the company's willingness to undertake bold measures to revitalize its performance and buoy its beleaguered share price. Conclusion: Bayer's ( OTC:BAYRY ) decision to revise its dividend policy represents a pivotal moment in its ongoing efforts to navigate choppy financial waters. As the company grapples with high debt, challenging cash flow dynamics, and analyst scrutiny, its strategic imperatives underscore a commitment to reshaping its business for sustained success. The road ahead may be fraught with challenges, but Bayer's ( OTC:BAYRY ) willingness to confront them head-on signals a determination to emerge stronger and more resilient in the face of adversity.
OTC:BAYRYLong
by DEXWireNews
Xiaomi's Internet Business Arm Expands PartnershipXiaomi's Internet Business Arm Expands Partnership with Digital Turbine to Power Global App Recommendations. The partnership expansion is the next step in Digital Turbine and Xiaomi's relationship, elevating the quality of app recommendations to Xiaomi smartphone end users around the world. Digital Turbine, the company that connects the mobile ecosystem through innovative experiences, today announced the expansion of its partnership with the International Internet Business Department of Xiaomi, one of the world's leading consumer electronics and smart manufacturing companies, bringing new and engaging app recommendations to Xiaomi mobile users around the world. Users purchasing new Xiaomi devices in most markets in EMEA, LATAM, APAC and MENA will enjoy premium app and mobile games recommendations delivered to the palm of their hands. Digital Turbine's technology is already delivered to over 800M devices around the world and today marks an important expansion in their global reach as the company expands its partnership with the second-largest Android phone manufacturer globally.
OTC:XIACFLong
by DEXWireNews
BZYR: Potential long term investment - with riskI've become interested in BZYR which trades only OTC at this time. Why is this OTC stock of high importance for long term investors? In order to set this out my post is broken into various parts: 1 - Introduction 2 - The historical battles 3 - Efficacy of a cancer treatment 4 - Summary 5 - The risk to reward for long term investors. The above cannot possibly avoid referring to organisations and materials in the public domain - as matters of fact and truth before the courts. Introduction: The founder has discovered a treatment for cancers that cannot be treated by conventional treatments, that is better than anything out there at this time. The research has been in the public domain for the last 30-odd years. The discovery is called Antineoplastons - which is a combination of various peptides and other 'chemicals'. Historical battles: The research evidence for efficacy has not been faulted. The FDA (in the public domain) took the founder through 4 grand juries. The case failed at the Texas State Supreme Court, in an attempt to remove the founder's medical licence. The whole story runs very deep back to the 1980s - but despite strenous efforts to shut down the treatment (and the founder), it persists to this day, through the endless legal battles. Staying within the 'House Rules' means that I am cautious not to breach. In 1982 the FDA stated " never have and never will approve a new drug to an individual but only to a large pharmaceutical firm with unlimited finances ." Therefrom sprung one of the most severe fights in FDA history. dealings with the FDA commenced in 1983 at that point the FDA commenced a civil action to try to close the clinic and stop all patients from receiving the medicine before the judge in this case. Before the judge in the 1983 court case had announced her ruling the FDA sends her a letter warning her in advance " if this court declines to grant the injunction sought by the government thus permitting continued manufacture and distribution of antineoplastons the government would then be obliged to pursue other less efficient remedies such as actions for seizure and condemnation of the drugs or criminal prosecution of individuals. " Efficacy of cancer treatment with Antineoplastons: Mainstream cancer research organisations will say " There is not enough reliable evidence to use it as a cancer treatment " or that the treatment is ' experimental '. But this is not true. If there has been an experiment, it was fully under the watch of the FDA, and the results are beyond belief for success. Double-blind randomised controlled trials in Japan have proved the superior efficacy of the treatment (which is not 100% but far better than what exists). Summary Antineoplaston treatment has weathered all battles for over 30 years. It's not going away. It's survival suggests something novel and unique has been discovered. Why is this treatment surviving at all? Why all the battles against it? Those are matters for you to ponder. The risk to reward for long term investors: The weeky chart will show that BZYR (an OTC stock) is near rock bottom and possibly in an accummulation phase. Note carefully that OTC stocks are not on conventional exchanges like NYSE and NASDAQ. The potential growth over a 5 year period could be significant in relation to a fixed risk of loss which should be an affordable one, if more research confirms it's specific kind of efficacy. This could be the next 'Amazon' of the biomedical world. As always I emphasise the risk - and I am unable to provide tips on how to manage that. Disclaimers apply.
OTC:BZYR
by Captain_Walker
MNMD Long based on Fundmntls, Lvls and MetaWorldCrypto indicatorHypothesis: pharmaceutical company price depressed due to conflict between management and investor, price artificially low due to FUD. Confluence on W1 charts: 1. Price near ATL and 2020 support levels (year of IPO), see Early 2020 Support, and 2020 Support Levels. 2. Advanced RSI in oversold band with three Regular Divergence -Bullish signals 3. Setups & Trends also showing same three Regular Divergence - Bullish signals (same signals as above) 4. StRSI <10% with K crossed up D Confluence on H1 chart 1. Price below Early 2020 and 2020 support levels and bouncing off Oct 2022 support. 2. Setup & Trend and Advanced RSI showing three Regular Divergence - Bull signals Position: Entered at $2.82 with SL at $2.70, TP1 at $3.75 Risk Management: RR 7.75, Portfolio Risk % 0.43%, SL% Loss 4.26%, TP1% Gain 32.98%
NASDAQ:MNMDLong
by metadimensional
IWMThe set up from LT support off the bottom channel has Nuked (of course) and I say that b c this year is the year where everything looks like a perfect set up that just nukes. (except oil trades) At this point IWM can still be an over throw, if small caps are pricing in all this inflation & War in Ukraine & recession talk. If the chart is to follow NQ then we have much more pain ahead. Looking at OTC stocks I am really unsure as to how much more pain can be endured. They all seem pretty bottomed. So watching for an MM overthrow here and confirmation would be working the candle sticks back into the LT channel IMO.
AMEX:IWMLong
by Big_Mike716
$DPLS entry PTs .0001-.0005 or next Spring Next Target PTs 4-17 DarkPulse, Inc., a technology-security company, develops, markets, and distributes a suite of engineering, installation, and security management solutions to industries and governments in the United States and internationally. The company's patented Brillouin optical time domain analyzer dark-pulse technology provides customer with a data stream of critical metrics for assessing the health and security of their infrastructure. It offers security platforms, including fiber optic and satellite communications services; and manufactures, sells, installs, and monitors laser sensing systems, and drone and rover systems, as well as offers oil and gas pipeline leak detection, physical security, and telecommunications and satellite communications services. The company focuses on delivering security and monitoring systems for border security, pipelines, the oil and gas industry, and mine safety applications. DarkPulse, Inc. is headquartered in New York, New York.
OTC:DPLSLong
by BADQOMOCAWGOWLD
$VYST entry PTs .0005-.002-.004 Next Target PTs .1-.15 and higheVystar Corporation manufactures and sells Vytex natural rubber latex (NRL) products to the manufacturers of rubber and rubber end products in the United States. Its products are used by manufacturers of a range of consumer and medical products, such as adhesives, gloves, balloons, condoms, and other medical devices, as well as natural rubber latex foam mattresses, toppers, and pillows. The company also offers RXair, an air purifier; and a range of residential furniture and decorative accessories. Vystar Corporation was founded in 2000 and is based in Worcester, Massachusetts.
OTC:VYSTLong
by BADQOMOCAWGOWLD
HYSR📈LETS GO BRANDON📉HYSRHey Fam.. Just an idea I wanted to share with you all about AN OTC stock with some huge potential.. Let me know what you think please add me and hit the like button if you like my idea I shared with you all.. Let me know if you have anymore Ideas you would like me to draw up I will always do my best.. Please remember.. Patience is your friend and so is the trend.. Don't fight it.. And you will be profitable with discipline and obedience..🔨🦴📉📈😉💯🎯❗🤷‍♂️
OTC:HYSRLong
by robinstallsforyou2
EPAZ attractive valuation right, under 10M. Still undiscoveredEPAZ attractive valuation right now, well under 10M market cap, with that said it should go up way higher. from here They’re launching Bitcoincredit/debit cards plus they’re in other hot sectors NFTs , CBD , Metaverse and making serious noise. EPAZ trading at such a low market cap. Most good crypto + metaverse + crypto stocks are trading at a 30M-50M market cap. Plenty of upside for $EPAZ here pretty much, it’s still very early #pennystocks #stockmarket #stocks #BTC ZenaPay Blockchain Bitcoin wallet will include credit cards/debit cards to the user wallet. The user will be able to store both fiat currency and cryptocurrency. This will be a major upgrade to the ZenaPay wallet. We are providing additional support to new cryptocurrencies. We are working towards gasless transactions and providing easy transfer to traditional bank accounts. Our primary mission is to become an alternative to bank checking accounts for businesses and allowing them to earn money from their investment into cryptocurrency. As we build out the infrastructure more opportunities will begin to arise. Epazz CEO Shaun Passley, PhD, stated, "We are creating technology for the next generation of payment solutions." Future ZenaPay upgrades to be released soon. ZenaPay (www.zenapay.com) is being developed to solve a major problem in high-risk industries. Traditional banking systems do not allow high-risk industries to access their payment systems. ZenaPay offers a cutting-edge payment solution that gives consumers a way to buy items online or in stores using Bitcoin. The new Bitcoin payment software will allow consumers to use digital currency to make online or in-store purchases with ease. The process will also be anonymous because all transaction details are encrypted through Bitcoin, which will enable stores to accept digital currency instead of only cash. ZenaPay is available on the App Store and Play Store. About Epazz, Inc. (www.epazz.com) Epazz, Inc. is a leading cloud-based-software company that specializes in providing customized cloud applications to the corporate world, higher-education institutions and the public sector. Epazz BoxesOS™ v3.0 is the complete business web-based software package for small- to mid-size businesses, Fortune 500 enterprises, government agencies and higher-education institutions. BoxesOS provides many of the web-based applications organizations would otherwise need to purchase separately. Epazz's other products are DeskFlex™ (a room scheduling software) and DeskFlex™ (an applicant-tracking system).
OTC:EPAZLong
by Bitplaza